All lobbying filings

LIBERTY PARTNERS GROUP, LLC

LIBERTY PARTNERS GROUP, LLC filed a Q3 report for TELIX PHARMACEUTICALS US on October 20, 2026, reporting $40,000 in lobbying income.

Lobbying for TELIX PHARMACEUTICALS US · Diagnostic radiopharmaceutical providing precision medicine to patients in the U.S.

All filings by LIBERTY PARTNERS GROUP, LLC · Everything TELIX PHARMACEUTICALS US has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Lobbyists on this filing 1

ANDREW COATS

Previously held: Legislative Assistant, Rep. Mark Souder

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

Medicare/Medicaid

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

Medical/Disease Research/Clinical Labs

Medicare reimbursement, working with Congress on legislation relating to the early detection and treatment of deadly diseases, Prescription Drug User Fee Amendments

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.